Silexion Therapeutics Corp (SLXN)
Data as of , from SEC Form 4 filings.
See up to 3 months of SLXN. The 7-day demo opens the 1M and 3M ranges and puts SLXN on your watchlist.
Start 7-day demoLatest SLXN insider trades
About Silexion Therapeutics Corp (SLXN)
Silexion Therapeutics Corp is a clinical-stage, oncology-focused biotechnology company engaged in the discovery and development of proprietary treatments for cancers driven by mutations in the mutations in the Kirsten rat sarcoma viral oncogene homolog (KRAS). Its proprietary technology is designed to prompt tumor cells to degrade the messenger RNA (mRNA) that bridges the oncogene and the cellular protein synthesis machinery, utilizing small interfering RNA (siRNA) constructs that are chemically modified to enhance stability and cellular uptake while maintaining biological activity that interferes with the mRNA function. Its product candidate, SIL204, is a second-generation siRNA engineered to suppress the production of mutated KRAS proteins.
- RAMAT GAN, L3
- 13
- 2024
- XNAS
SLXN Form 4 activity by transaction type, last 90 days
No Form 4 activity for SLXN in the last 90 days.
SLXN insider transactions (Form 4)
2013 Form 4 filings on record, the earliest from Jan 27, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mitchell Shirvan - Officer | Grant or award | Ordinary Shares | 6,000 | $0.00 | - | |
| Hadar Mirit Horenshtein - Officer | Grant or award | Ordinary Shares | 7,500 | $0.00 | - | |
| Ilan Hadar - Officer | Grant or award | Ordinary Shares | 10,000 | $0.00 | - | |
| Mitchell Shirvan - Officer | Open-market sale | Ordinary Shares | 22,818 | $13.60 | $31K | |
| Shlomo Noy - Director | Grant or award | Ordinary Shares | 9,091 | $0.00 | - | |
| Shlomo Noy - Director | Grant or award | Stock Option (right to buy ordinary shares) | 10,685 | $0.00 | - | |
| Ruth Alon - Director | Grant or award | Ordinary Shares | 9,091 | $0.00 | - | |
| Ruth Alon - Director | Grant or award | Stock Option (right to buy Ordinary Shares) | 10,685 | $0.00 | - | |
| Mitchell Shirvan - Officer | Grant or award | Ordinary Shares | 49,726 | $0.00 | - | |
| Hadar Mirit Horenshtein - Officer | Grant or award | Ordinary Shares | 49,726 | $0.00 | - | |
| Ilan Hadar - Officer | Grant or award | Ordinary Shares | 64,350 | $0.00 | - | |
| Dror Yosef Abramov - Director | Grant or award | Ordinary Shares | 9,091 | $0.00 | - | |
| Dror Yosef Abramov - Director | Grant or award | Stock Option (right to buy ordinary shares) | 10,685 | $0.00 | - | |
| Amnon Peled - Director | Grant or award | Ordinary Shares | 7,576 | $0.00 | - | |
| Amnon Peled - Director | Grant or award | Stock Option (right to buy Ordinary Shares) | 8,904 | $0.00 | - | |
 Avner Lushi - Director | Grant or award | Ordinary Shares | 9,091 | $0.00 | - | |
| Avner Lushi - Director | Grant or award | Stock Option (right to buy ordinary shares) | 10,685 | $0.00 | - | |
| Ilan Levin - Director | Other | Ordinary Shares | 5,550 footnote F2 | $0.00 | - | |
| Ilan Levin - Director | Grant or award | Ordinary Shares | 450,000 footnote F4 | $40.00 | $1.80M | |
| Ilan Levin - Director | Other | Warrant (right to buy) | 935 footnote F7 | $0.00 | - | |
| ||||||
SLXN insider trading FAQ
What is the latest insider trade for SLXN?
Silexion Therapeutics Corp (SLXN) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-08. The full record for SLXN runs to 13 Form 4 filings, the earliest from 2026-01-27. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying SLXN stock?
No insider purchases of SLXN were filed in the last 90 days.
How many insiders are selling SLXN stock?
No insider sales of SLXN were filed in the last 90 days. 1 sale is on record for this company.
Where can I see SLXN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects SLXN Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Mitchell Shirvan view on EDGAR
- - Hadar Mirit Horenshtein view on EDGAR
- - Ilan Hadar view on EDGAR
- - Mitchell Shirvan view on EDGAR
- - Shlomo Noy view on EDGAR
- - Ruth Alon view on EDGAR
- - Mitchell Shirvan view on EDGAR
- - Hadar Mirit Horenshtein view on EDGAR
- - Ilan Hadar view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where SLXN's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow SLXN with a 7-day demo
- SLXN on your watchlist
- Every SLXN Form 4 filing on record
- Up to 3 months of SLXN price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
